• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OLYMPUS MEDICAL SYSTEMS CORP. OES CYSTONEPHROFIBERSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OLYMPUS MEDICAL SYSTEMS CORP. OES CYSTONEPHROFIBERSCOPE Back to Search Results
Model Number CYF-5A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Inflammation (1932)
Event Date 09/23/2020
Event Type  Injury  
Manufacturer Narrative
The device was returned to olympus medical systems corp.(omsc) for evaluation.Omsc will start evaluating the device.There were no further details provided.If significant additional information is received, this report will be supplemented.
 
Event Description
Olympus medical systems corp.(omsc) was informed that five patients developed cystitis after procedures using this product.The device had been reprocessed by an non-olympus automated reprocessing machine espal.According to the user facility, the manufacturer has confirmed the reprocessing machine has no problem.Therefore, the user facility suspects that the olympus endoscope caused the patient infections and contacted olympus to ask for investigation.A total of five reports are being submitted for the five patients.This is the 5th of 5 reports.
 
Manufacturer Narrative
This supplemental report is being submitted to provide additional information.The evaluation of the subject device by olympus medical systems corp.(omsc) confirmed following: the device passed the leakage testing.Some residues remained on the light guide lens, the objective lens and the distal end of the instrument channel.The residue on the distal end of the instrument channel could be easily scrubbed off.It is considered that the remained residues caused due to insufficient reprocessing.Omsc reviewed the manufacture history (dhr) of the device and confirmed no irregularity.The exact cause of the reported phenomenon could not be conclusively determined.However, it is unlikely that the reported event occurred due to the scope, because there was no damage that may result in insufficient reprocessing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OES CYSTONEPHROFIBERSCOPE
Type of Device
CYSTONEPHROFIBERSCOPE
Manufacturer (Section D)
OLYMPUS MEDICAL SYSTEMS CORP.
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8 507
JA  192-8507
MDR Report Key10716977
MDR Text Key213483976
Report Number8010047-2020-07994
Device Sequence Number1
Product Code FAJ
Combination Product (y/n)N
PMA/PMN Number
K032092
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type user facility
Type of Report Initial,Followup
Report Date 12/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberCYF-5A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/07/2020
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 09/23/2020
Initial Date FDA Received10/22/2020
Supplement Dates Manufacturer Received12/15/2020
Supplement Dates FDA Received12/24/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-